Search
Dissolution testing of powders for inhalation
Publication
May S
(2013)
Book
Book
Pulmonary surfactant is indispensable in order to simulate the in vivo situation
Publication
Schleh C,
Kreyling W,
Lehr C
(2013)
Particle and Fibre Toxicology, 10, 1, 10.1186/1743-8977-10-6, 23531298
Particle and Fibre Toxicology, 10, 1, 10.1186/1743-8977-10-6, 23531298
Finite dose skin mass balance including the lateral part: Comparison between experiment, pharmacokinetic modeling and diffusion models
Publication
Selzer D,
Hahn T,
Naegel A,
Heisig M,
Kostka K,
Lehr C,
Neumann D,
Schaefer U,
Wittum G
(2013)
Journal of Controlled Release, 165, 2, 119-128, 10.1016/j.jconrel.2012.10.009, 23099116
Journal of Controlled Release, 165, 2, 119-128, 10.1016/j.jconrel.2012.10.009, 23099116
Budesonide Loaded pH-sensitive PLGA Nanoparticles for the Treatment of Inflammatory Bowel Disease
Publication
Ali H
(2013)
Non-invasive delivery of nanoparticles to hair follicles: A perspective for transcutaneous immunization
Publication
Mittal A,
Raber A,
Schaefer U,
Weissmann S,
Ebensen T,
Schulze K,
Guzmán C,
Lehr C,
Hansen S
(2013)
Vaccine, 31, 34, 3442-3451, 10.1016/j.vaccine.2012.12.048, 23290836
Vaccine, 31, 34, 3442-3451, 10.1016/j.vaccine.2012.12.048, 23290836
Nanomedicines for the treatment of inflammatory bowel diseases
Publication
Ali H,
Collnot E,
Windbergs M,
Lehr C
(2013)
European Journal of Nanomedicine, 5, 1, 10.1515/ejnm-2013-0004
European Journal of Nanomedicine, 5, 1, 10.1515/ejnm-2013-0004
From the structure of the skin barrier and dermal formulations to in vitro transport models for skin absorption
Publication
Windbergs M,
Hansen S,
Schroeter A,
Schaefer U,
Lehr C,
Bouwstra J
(2013)
Skin Pharmacology and Physiology, 26, 4-6, 317-330, 10.1159/000351936
Skin Pharmacology and Physiology, 26, 4-6, 317-330, 10.1159/000351936
Particle based vaccine formulations for transcutaneous immunization
Publication
Mittal A,
Raber A,
Lehr C,
Hansen S
(2013)
Human Vaccines and Immunotherapeutics, 9, 9, 1950-1955, 10.4161/hv.25217
Human Vaccines and Immunotherapeutics, 9, 9, 1950-1955, 10.4161/hv.25217
PEG-functionalized microparticles selectively target inflamed mucosa in inflammatory bowel disease
Publication
Lautenschläger C,
Schmidt C,
Lehr C,
Fischer D,
Stallmach A
(2013)
European Journal of Pharmaceutics and Biopharmaceutics, 85, 3 PART A, 578-586, 10.1016/j.ejpb.2013.09.016, 24084650
European Journal of Pharmaceutics and Biopharmaceutics, 85, 3 PART A, 578-586, 10.1016/j.ejpb.2013.09.016, 24084650
Novel cell based in vitro models to study nanoparticle interaction with the inflamed intestinal mucosa
Publication
Leonard F
(2013)
Book
Book